Oral and maxillofacial pathology case of the month. Palatal melanosis associated with imatinib mesylate therapy

Tex Dent J. 2012 Aug;129(8):764-5, 786-8.

Authors

Yau-Hua Yu¹, Yusuf Shere, Nadarajah Vigneswaran

Affiliation

¹ Department of Diagnostic and Biomedical Sciences, The University of Texas School of Dentistry at Houston, USA.

PMID: 22988661

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Agents / adverse effects*
Benzamides
Diagnosis, Differential
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / enzymology
Male
Melanosis / chemically induced*
Mouth Mucosa / drug effects
Palate, Hard
Piperazines / adverse effects*
Protein Kinase Inhibitors / adverse effects*
Protein-Tyrosine Kinases / antagonists & inhibitors
Pyrimidines / adverse effects*

Substances

Antineoplastic Agents
Benzamides
Piperazines
Protein Kinase Inhibitors
Pyrimidines
Imatinib Mesylate
Protein-Tyrosine Kinases